Mark Ragosa is CHIEF FINANCIAL OFFICER of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 31,086 shares of KNSA, which is worth approximately $1.2 Million. The most recent transaction as insider was on Dec 31, 2020, when has been sold 4,404 shares (Class A Common Share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.1K
15.09% 3M change
35.4% 12M change
Total Value Held $1.2 Million

Mark Ragosa Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 31 2020
BUY
Exercise of conversion of derivative security
-
4,404 Added 50.0%
4,404 Class A Common Share
MR

Mark Ragosa

CHIEF FINANCIAL OFFICER
Hamilton, D0

Track Institutional and Insider Activities on KNSA

Follow Kiniksa Pharmaceuticals, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Track Activities on KNSA